October 17, 2011
Bayer HealthCare of Germany and Onyx Pharmaceuticals of the US have announced the restructuring of their global oncology partnership. In addition to the current development and marketing agreement for Nexavar (sorafenib), the two companies have entered into a new agreement...read more